Cite Filings / ACRV / 9999999995-22-003246

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Acrivon Therapeutics, Inc. Filed 2022-11-09 Acc 9999999995-22-003246

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-12-15 EFFECT Notice of Effectiveness
2022-11-09 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2022-11-09 EFFECT Notice of Effectiveness
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership
2022-11-09 3 Initial Statement of Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…